Wearable neurotech company NeuroLife launches with $2.9M to restore movement after stroke

Funding
NeuroLife, the market-facing brand of ActivateNeuro, Inc., has launched out of a strategic partnership between Battelle and The NeuroTech Institute to develop non-invasive neurotechnology for stroke and spinal cord injury rehabilitation. Related: Nanoflex Robotics Awarded...

Wearable neurotech company NeuroLife launches with $2.9M to restore movement after stroke

Funding
NeuroLife, the market-facing brand of ActivateNeuro, Inc., has launched out of a strategic partnership between Battelle and The NeuroTech Institute to develop non-invasive neurotechnology...

Nanoflex Robotics Awarded €12.5 Million from the EIC Accelerator

Funding
Nanoflex Robotics AG has secured €12.5 million in blended financing from the prestigious European Innovation Council Accelerator, consisting of a €2.5 million grant and...

Lumitron closes USD $50 million investment for HyperVIEW platform

Funding
Hancock Prospecting has invested USD $50 million in Lumitron, with the option to increase its funding to USD $100 million this year. This capital...

GS MedTech Funding Tracker – Tissium, CroíValve, and more

GS Funding Tracker
Commercial expansion, clinical validation, and next-generation technologies defined this week's MedTech funding activity. Investors continued to back innovation, with funding spanning surgical robotics, cardiovascular...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Coherence Neuro begins first clinical study for BCI

Coherence Neuro has initiated its first clinical study of the investigational Cipher brain-computer interface (BCI), marking its transition into human testing. The study, led by...

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism

Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, evaluating the impact of early mechanical thrombectomy in patients with intermediate-risk...

VahatiCor enrolls first U.S. patient in SERRA-I clinical study of A-FLUX Reducer System

VahatiCor has enrolled the first U.S. patient in its SERRA-I early feasibility study, evaluating the investigational A-FLUX Reducer System® for patients with coronary microvascular...

Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing...

Innovation

Regulatory Approvals

Wearable neurotech company NeuroLife launches with $2.9M to restore movement after stroke

NeuroLife, the market-facing brand of ActivateNeuro, Inc., has launched out of a strategic partnership between Battelle and The NeuroTech Institute to develop non-invasive neurotechnology...

Nanoflex Robotics Awarded €12.5 Million from the EIC Accelerator

Nanoflex Robotics AG has secured €12.5 million in blended financing from the prestigious European Innovation Council Accelerator, consisting of a €2.5 million grant and...

Lumitron closes USD $50 million investment for HyperVIEW platform

Hancock Prospecting has invested USD $50 million in Lumitron, with the option to increase its funding to USD $100 million this year. This capital...

GS MedTech Funding Tracker – Tissium, CroíValve, and more

Commercial expansion, clinical validation, and next-generation technologies defined this week's MedTech funding activity. Investors continued to back innovation, with funding spanning surgical robotics, cardiovascular...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1166Regulatory Approvals1032Innovation656Clinical Trials530Mergers & Acquisitions511GS Funding Tracker55